Previous studies provided evidence that elevated levels of USP25 are linked to the progression of different cancer types such as non-small-cell lung carcinoma (NSCLC) [39], which are characterized by EGFR genetic alterations and aberrant EGFR signaling. Here, EGFR is linked to cancer.